TABLE 3

Prognostic Factors in Multivariable Regression for PFS and OS According to Entire Cohort and ⁹⁰Y Resin and Glass Groups

	PFS		OS
Characteristic	HR (95% CI)	P	HR (95% CI)	P
All population (n = 77)
BCLC staging system, stages A and B vs. stage C	0.59 (0.30–1.15)	0.12	0.63 (0.33–1.19)	0.15
Tumor size, <5 vs. ≥5 cm	0.94 (0.70–1.25)	0.66	0.85 (0.59–1.22)	0.37
Serum AFP level	0.76 (0.38–1.52)	0.43	0.84 (0.58–1.20)	0.37
⁹⁰Y resin group (n = 41)
BCLC staging system, stages A and B vs. stage C	0.85 (0.35–2.03)	0.71	0.49 (0.20–1.19)	0.12
Tumor size, <5 vs. ≥5 cm	0.52 (0.19–1.42)	0.20	0.62 (0.24–1.63)	0.33
Serum AFP level	0.85 (0.60–1.20)	0.35	0.65 (0.38–1.11)	0.11
⁹⁰Y glass group (n = 36)
BCLC staging system, stages A and B vs. stage C	0.27 (0.08–0.96)	0.04	0.74 (0.23–2.44)	0.62
Tumor size, <5 vs. ≥5 cm	1.87 (0.55–6.40)	0.32	0.93 (0.30–2.93)	0.90
Serum AFP level	1.73 (0.99–3.01)	0.06	1.72 (1.02–2.90)	0.04